Abstract
The individualization of cytostatic agent dose is an actual problem in isolated lung chemoperfusion (ILP). Hitherto it has been carried out according to anthropometric data, in particular, the surface area of the body. A biophysical model of ILP based on diffusion cisplatin transfer in the lung is proposed. The model indicates to get the individual drug dose according to physical lung volume, which can be measured by CT-volumetry. Cisplatin pharmacokinetics and model compliance with actual data are considered on the material of 28 ILP. Estimates of lung interstitial and vascular space volumes and diffusion characteristic of capillary membrane are obtained.References
Чиссов В.И., Трахтенберг А.Х., Пикин О.В., Паршин В.Д. Метастатические опухоли легких. - М.: ГЭОТАР-Медиа., 2009. - 160 с.
Van Schil, P.E. Isolated lung perfusion and related techniques for the treatment of pulmonary metastases / PE. Van Schil, J.M. Hendriks, B.P Van Putte et al. // Eur. j. cardiothoracic. surg. - 2008. - Vol. 33. - P. 487-496.
Тимофеева, Е.С. Изолированная химиоперфузия лёгкого в комбинированном лечении метастатического поражения лёгких: Дисс.. канд. мед. наук / Е.С. Тимофеева. - СПб., 2011. - 178 с.
den Hengst W.A., Hendriks J.M., Balduyck B. et al. Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases // J. Thorac. Oncol. - 2014. - Vol. 9(10). - P. 1547-1553.
Hendriks J.M.H., Grootenboers M.J., Schramel F.M. et al. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial // Ann. Thorac. Surg. - 2004. - Vol. 78. - P. 1919-1926.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2018